Exsilio

Developer of genomic medicines for a broad range of diseases

placeBoston, Massachusetts, United States calendar_todayFounded 2022 language exsiliotx.com

Social engagement

Social engagement: 4.4K social following, 4 posts in the last 12 months — top quartile of its industry.

Investor mix

10 investors on record; lead investors include Novartis Venture Fund, Delos Capital, Orbimed.

Investor typeCountShare
Venture capital440%
Private equity330%
Bank & private debt110%
Other / undisclosed220%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

Based on job postings tracked across public sources.

Recent activity

9 Jan 2026
Event
44th Annual J.P. Morgan Healthcare Conference
22 Sep 2025
Recognition
19 Sep 2025
Recognition
Coming soon